This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The FTC’s legal fight against three major pharmacy benefit managers is on hold a...
As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and ...
New FDA Commissioner Marty Makary took to the stage at the agency's Maryland hea...
The app allows users to self-reflect via text, voice, image or video.
Plus, news about Sumitomo Pharma, Gilead, Roche, Desentum, Inhibrx and Pila Phar...
Eli Lilly’s direct-to-consumer service has added another telehealth startup to i...
What You Should Know: – University Hospitals Cleveland Medical Center (UH) has...
AI adoption in healthcare needs to shift from “what’s possible” to “what’s respo...
John Crowley is clear-eyed about the obstacles he faces. As CEO of the trade gro...
According to Tom Niehaus, Executive Vice President at CTG, securing your own org...
Tang Capital's shell company Concentra Biosciences secured its first major deal ...
Plus, news about Gilead, Roche, Desentum, Inhibrx and Pila Pharma: After 202...
The following is a guest article by Rob Shavell, CEO at DeleteMe Healthcare cybe...
Cybersecurity and data protection in healthcare is only as strong as its weakest...
AI tools can work together across the payer value chain, exchanging information,...
It can be very overwhelming scrolling though job board after job board in search...